Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin for OAB in Women With Vaginal Prolapse and a Pessary
NCT01092624Phase 4Terminated
- Sponsor
- Hartford Hospital
- Start
- Mar 2010
- Primary completion
- Oct 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of solifenacin in overactive bladder (OAB), sponsored by Hartford Hospital. Started Mar 2010; status: terminated.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01092624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01092624.